These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16818649)

  • 1. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
    Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
    Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.
    Popivanova BK; Li YY; Zheng H; Omura K; Fujii C; Tsuneyama K; Mukaida N
    Cancer Sci; 2007 Mar; 98(3):321-8. PubMed ID: 17270021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.
    Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY
    Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
    Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY
    Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.
    Wang Z; Li XM; Shang K; Zhang P; Wang CF; Xin YH; Zhou L; Li YY
    Oncol Rep; 2013 Mar; 29(3):1245-51. PubMed ID: 23314349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
    Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
    Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
    Jian J; Hu ZF; Huang Y
    Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.
    Aho TL; Sandholm J; Peltola KJ; Mankonen HP; Lilly M; Koskinen PJ
    FEBS Lett; 2004 Jul; 571(1-3):43-9. PubMed ID: 15280015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells.
    Li YY; Wu Y; Tsuneyama K; Baba T; Mukaida N
    Cancer Sci; 2009 Mar; 100(3):396-404. PubMed ID: 19154409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.
    Wang C; Li HY; Liu B; Huang S; Wu L; Li YY
    J Surg Res; 2013 Dec; 185(2):595-604. PubMed ID: 23845873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.
    Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A
    Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
    Gong J; Wang J; Ren K; Liu C; Li B; Shi Y
    J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
    Xu D; Cobb MG; Gavilano L; Witherspoon SM; Williams D; White CD; Taverna P; Bednarski BK; Kim HJ; Baldwin AS; Baines AT
    Cancer Biol Ther; 2013 Jun; 14(6):492-501. PubMed ID: 23760491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively activated FLT3 phosphorylates BAD partially through pim-1.
    Kim KT; Levis M; Small D
    Br J Haematol; 2006 Sep; 134(5):500-9. PubMed ID: 16869825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
    Wingett D; Long A; Kelleher D; Magnuson NS
    J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIM kinases: an overview in tumors and recent advances in pancreatic cancer.
    Xu J; Zhang T; Wang T; You L; Zhao Y
    Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Pim-3, a novel survival kinase, in tumorigenesis.
    Mukaida N; Wang YY; Li YY
    Cancer Sci; 2011 Aug; 102(8):1437-42. PubMed ID: 21518143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75.
    Zhang B; Zhang Y; Shacter E
    Mol Cell Biol; 2004 Jul; 24(14):6205-14. PubMed ID: 15226424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligodeoxynucleotides targeting the serine/threonine kinase Pim-2 inhibited proliferation of DU-145 cells.
    Dai JM; Zhang SQ; Zhang W; Lin RX; Ji ZZ; Wang SQ
    Acta Pharmacol Sin; 2005 Mar; 26(3):364-8. PubMed ID: 15715935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.